Skip to content
    Morningside logo

    Morningside

    Newton, Massachusetts, United StatesFounded 1986

    Morningside is a private investment group founded in 1986 by the Chan family of Hong Kong. The firm makes venture capital and private equity investments in companies with novel science and technology, characterized by a long-term outlook in company-building.

    Average disclosed round size is $61.7M (across 176 rounds with reported amounts).

    Find people at Morningside on Goldilocks AI

    Portfolio

    139

    Fund Size

    —

    Top Stage

    Series B

    Last 12 Mo

    5

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    204 investments
    CompanyRoundAmountDate
    Dewey logoDeweySeries A$5MJul 2026
    SimpliFed logoSimpliFedSeries A$10.8MApr 2026
    Cognito logoCognitoSeries C$105MMar 2026
    Ampa Health logoAmpa HealthSeed$8.5MOct 2025
    Brook logoBrookSeries B$28MOct 2025
    CCyted HealthSeries B$44MSep 2025
    Accropeutics Inc. logoAccropeutics Inc.Series B$12MMar 2025
    SimpliFed logoSimpliFedSeed$4MFeb 2025
    Geneoscopy logoGeneoscopySeries C$105MJan 2025
    Alebund logoAlebundSeries C—Jan 2025
    AdvanCell logoAdvanCellSeries C$112MJan 2025
    Cyted logoCytedSeries B$44MJan 2025
    CCyted HealthUnknown$44MJan 2025
    NuCana logoNuCanaSeries B—Jan 2025
    AAlentisSeries D$181.4MNov 2024
    Kappa Pay logoKappa PaySeed$5MApr 2024
    AAlamar Biosciences, Inc.Series C$128MFeb 2024
    FlyteHealth logoFlyteHealthSeries A$24MJan 2024
    FF2GSeries H$100MJan 2024
    Eko Health logoEko HealthSeries C$125MJan 2024
    Alentis Therapeutics logoAlentis TherapeuticsSeries D$181.4MJan 2024
    Eko logoEkoSeries C$125MJan 2024
    Jitjatjo logoJitjatjoSeries B$30MDec 2023
    EEpigenic TherapeuticsSeries A$32MAug 2023
    Epigenic logoEpigenicSeries A$32MAug 2023
    Page 1 of 9

    Top Co-Investors

    Last updated: 20 October 2026